Iomedico Ag
Clinical trials sponsored by Iomedico Ag, explained in plain language.
-
New drug elacestrant tested in real-world breast cancer study
Disease control Not yet recruitingThis study will follow 500 postmenopausal women with advanced ER+ HER2- breast cancer that has an ESR1 mutation. Participants will receive elacestrant (Orserdu®) as part of their normal care. Researchers will track quality of life, side effects, and how the drug is used in everyd…
Sponsor: iOMEDICO AG • Aim: Disease control
Last updated Jun 23, 2026 11:59 UTC
-
New hope for Hard-to-Treat myeloma: Real-World study launches for melflufen combo
Disease control Not yet recruitingThis study looks at how well the drug combination melflufen (Pepaxti®) and dexamethasone works for people with multiple myeloma that has come back or stopped responding to other treatments. It will include about 50 patients who have already tried at least three prior therapies. T…
Sponsor: iOMEDICO AG • Aim: Disease control
Last updated Jun 18, 2026 11:48 UTC